APG
Abacus Planning Group’s Pacific Biosciences PACB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $124K | Hold |
100,000
| – | – | 0.02% | 237 |
|
2025
Q1 | $118K | Hold |
100,000
| – | – | 0.02% | 223 |
|
2024
Q4 | $183K | Hold |
100,000
| – | – | 0.03% | 209 |
|
2024
Q3 | $170K | Hold |
100,000
| – | – | 0.03% | 205 |
|
2024
Q2 | $137K | Hold |
100,000
| – | – | 0.03% | 203 |
|
2024
Q1 | $375K | Hold |
100,000
| – | – | 0.07% | 129 |
|
2023
Q4 | $981K | Hold |
100,000
| – | – | 0.21% | 71 |
|
2023
Q3 | $835K | Hold |
100,000
| – | – | 0.2% | 77 |
|
2023
Q2 | $1.33M | Sell |
100,000
-20,000
| -17% | -$266K | 0.32% | 45 |
|
2023
Q1 | $1.39M | Hold |
120,000
| – | – | 0.36% | 41 |
|
2022
Q4 | $982K | Sell |
120,000
-20,000
| -14% | -$164K | 0.27% | 59 |
|
2022
Q3 | $813K | Hold |
140,000
| – | – | 0.25% | 64 |
|
2022
Q2 | $619K | Hold |
140,000
| – | – | 0.18% | 85 |
|
2022
Q1 | $1.27M | Sell |
140,000
-15,000
| -10% | -$137K | 0.34% | 51 |
|
2021
Q4 | $3.17M | Sell |
155,000
-25,000
| -14% | -$511K | 0.85% | 22 |
|
2021
Q3 | $4.6M | Hold |
180,000
| – | – | 1.46% | 13 |
|
2021
Q2 | $6.3M | Hold |
180,000
| – | – | 1.92% | 11 |
|
2021
Q1 | $6M | Sell |
180,000
-220,000
| -55% | -$7.33M | 1.92% | 11 |
|
2020
Q4 | $10.4M | Sell |
400,000
-302,937
| -43% | -$7.86M | 3.2% | 8 |
|
2020
Q3 | $6.94M | Buy |
+702,937
| New | +$6.94M | 2.53% | 9 |
|